PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29981795 ↗2018Reported benefit

Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death.

MouseChemical/toxinC57BL/6 wild type and aldehyde dehydrogenase 2 knockoutPretreatment before cyclophosphamide administration

Model: High-dose cyclophosphamide-induced acute cardiotoxicity

Aldehyde dehydrogenase 2 knockout mice were more susceptible to cyclophosphamide cardiotoxicity, and Alda-1 pretreatment markedly reduced toxic aldehyde accumulation, cardiac cell death and cardiac dysfunction without reducing the antitumour effect of cyclophosphamide.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.